CompletedNot Applicable

Probiotics in Paediatric Asthma Management

Italy46 participantsStarted 2017-04-21

Plain-language summary

Randomized controlled double-blind trial in a child population with allergic asthma and recurring wheezing, undergoing probiotic treatment with Bifiasthm with the aim of assessing the reduction in asthma attacks.

Who can participate

Age range1 Year – 14 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The study will include all children aged 6 to 14, with slight and moderate persistent asthma according to GINA 2015 criteria (asthma classification did not change in GINA 2015 and 2016 guidelines), whether or not showing positive skin allergometric tests, as well as all children aged 2 yrs, 364 days to 5 years, 364 days, with recurring wheezing, whether or not diagnosed with asthma (positive and/or negative prick). Exclusion Criteria: * Severe persistent asthma * Known congenital or acquired immunodeficiencies * Cystic fibrosis * Chronic pulmonary diseases (bronchodysplasia) * Age \< 1 yr, 364d and 14 yrs

What they're measuring

Reduction in Asthma episodes

Timeframe: 12 months

Reduction in wheezing

Timeframe: 12 months

Trial details

NCT IDNCT04289441

SponsorProbiotical S.p.A.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2019-04-21

View on ClinicalTrials.gov More Asthma in Children trials